These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 24966174)

  • 21. Use of insulin-like growth factor-binding protein-2 (IGFBP-2), IGFBP-3, and IGF-I for assessing growth hormone status in short children.
    Smith WJ; Nam TJ; Underwood LE; Busby WH; Celnicker A; Clemmons DR
    J Clin Endocrinol Metab; 1993 Nov; 77(5):1294-9. PubMed ID: 7521346
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The advantage of measuring spontaneous growth hormone (GH) secretion compared with the insulin tolerance test in the diagnosis of GH deficiency in young adults.
    Radetti G; di Iorgi N; Paganini C; Gastaldi R; Napoli F; Lorini R; Maghnie M
    Clin Endocrinol (Oxf); 2007 Jul; 67(1):78-84. PubMed ID: 17466007
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum homocysteine concentrations in children with growth hormone (GH) deficiency before and after 12 months GH replacement.
    Esposito V; Di Biase S; Lettiero T; Labella D; Simeone R; Salerno M
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):607-11. PubMed ID: 15521964
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of body mass index on the growth hormone response to clonidine stimulation testing in children with short stature.
    Loche S; Guzzetti C; Pilia S; Ibba A; Civolani P; Porcu M; Minerba L; Casini MR
    Clin Endocrinol (Oxf); 2011 Jun; 74(6):726-31. PubMed ID: 21521260
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The cut-off limits of the GH response to GH-releasing hormone-arginine test related to body mass index.
    Corneli G; Di Somma C; Baldelli R; Rovere S; Gasco V; Croce CG; Grottoli S; Maccario M; Colao A; Lombardi G; Ghigo E; Camanni F; Aimaretti G
    Eur J Endocrinol; 2005 Aug; 153(2):257-64. PubMed ID: 16061832
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Establishment and validation of predictive model of short term responses to recombinant human growth hormone treatment in prepubertal short stature children with various growth hormone secretary statuses].
    Su Z; Li YH; Ma HM; Chen HS; DU ML; Gu YF
    Zhonghua Er Ke Za Zhi; 2008 Oct; 46(10):757-62. PubMed ID: 19099881
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Growth hormone (GH) pharmacogenetics: influence of GH receptor exon 3 retention or deletion on first-year growth response and final height in patients with severe GH deficiency.
    Jorge AA; Marchisotti FG; Montenegro LR; Carvalho LR; Mendonca BB; Arnhold IJ
    J Clin Endocrinol Metab; 2006 Mar; 91(3):1076-80. PubMed ID: 16291702
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Somatostatin pretreatment enhances growth hormone (GH) responsiveness to GH-releasing hormone: a potential new diagnostic approach to GH deficiency.
    Tzanela M; Guyda H; Van Vliet G; Tannenbaum GS
    J Clin Endocrinol Metab; 1996 Jul; 81(7):2487-94. PubMed ID: 8675565
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IGF-I and IGF binding protein-3 levels during initial GH dosage step-up are indicators of GH sensitivity in GH-deficient children and short children born small for gestational age.
    Ranke MB; Traunecker R; Martin DD; Schweizer R; Schwarze CP; Wollmann HA; Binder G
    Horm Res; 2005; 64(2):68-76. PubMed ID: 16113581
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Variable degree of growth hormone (GH) and insulin-like growth factor (IGF) sensitivity in children with idiopathic short stature compared with GH-deficient patients: evidence from an IGF-based dosing study of short children.
    Cohen P; Germak J; Rogol AD; Weng W; Kappelgaard AM; Rosenfeld RG;
    J Clin Endocrinol Metab; 2010 May; 95(5):2089-98. PubMed ID: 20207829
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Usefulness of growth hormone (GH) stimulation tests and IGF-I concentration measurement in GH deficiency diagnosis.
    Obara-Moszyńska M; Kedzia A; Korman E; Niedziela M
    J Pediatr Endocrinol Metab; 2008 Jun; 21(6):569-79. PubMed ID: 18717243
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Secondary IGF-I deficiency as a prognostic factor of growth hormone (GH) therapy effectiveness in children with isolated, non-acquired GH deficiency.
    Smyczyńska J; Stawerska R; Hilczer M; Lewiński A
    Exp Clin Endocrinol Diabetes; 2015 Apr; 123(4):209-14. PubMed ID: 25607339
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Do all patients with childhood-onset growth hormone deficiency (GHD) and ectopic neurohypophysis have persistent GHD in adulthood?
    Léger J; Danner S; Simon D; Garel C; Czernichow P
    J Clin Endocrinol Metab; 2005 Feb; 90(2):650-6. PubMed ID: 15546901
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cut-off values of serum growth hormone (GH) in pharmacological stimulation tests (PhT) evaluated in short-statured children using a chemiluminescent immunometric assay (ICMA) calibrated with the International Recombinant Human GH Standard 98/574.
    Chaler EA; Ballerini Ga; Lazzati JM; Maceiras M; Frusti M; Bergada I; Rivarola MA; Belgorosky A; Ropelato G
    Clin Chem Lab Med; 2013 May; 51(5):e95-7. PubMed ID: 23095200
    [No Abstract]   [Full Text] [Related]  

  • 35. Growth hormone (GH) provocative retesting of 108 young adults with childhood-onset GH deficiency and the diagnostic value of insulin-like growth factor I (IGF-I) and IGF-binding protein-3.
    Juul A; Kastrup KW; Pedersen SA; Skakkebaek NE
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1195-201. PubMed ID: 9100596
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative study of human growth hormone measurements: impact on clinical interpretation.
    Lotierzo M; Olaru-Soare F; Dupuy AM; Plawecki M; Paris F; Cristol JP
    Clin Chem Lab Med; 2022 Jan; 60(2):191-197. PubMed ID: 34850616
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of body mass index on growth hormone stimulation tests in children and adolescents: a systematic review and meta-analysis.
    Abawi O; Augustijn D; Hoeks SE; de Rijke YB; van den Akker ELT
    Crit Rev Clin Lab Sci; 2021 Dec; 58(8):576-595. PubMed ID: 34431447
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stability of IGF-I concentration despite divergent results of repeated GH stimulating tests indicates poor reproducibility of test results.
    Hilczer M; Smyczynska J; Stawerska R; Lewinski A
    Endocr Regul; 2006 Jun; 40(2):37-45. PubMed ID: 17100545
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of two growth hormone stimulation tests and their cut-off limits in healthy adults at an outpatient clinic.
    Markkanen HM; Pekkarinen T; Välimäki MJ; Alfthan H; Hämäläinen E; Stenman UH
    Growth Horm IGF Res; 2013 Oct; 23(5):165-9. PubMed ID: 23835226
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum concentration of 20K human growth hormone (20K hGH) measured by a specific enzyme-linked immunosorbent assay. Study Group of 20K hGH.
    Tsushima T; Katoh Y; Miyachi Y; Chihara K; Teramoto A; Irie M; Hashimoto Y
    J Clin Endocrinol Metab; 1999 Jan; 84(1):317-22. PubMed ID: 9920101
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.